The overall aim of the research is to develop new radiopharmaceuticals for clinical human use in close collaboration with university hospitals and other research institutes. The research is based on a synergy between knowledge related to the GMP production of radiopharmaceuticals and fundamental disciplines within nuclear physics, radio-chemistry, -biology and -pharmacy.
The section also offers a variety of radioactive isotopes for medical and technical purposes based on irradiation either by protons on DTU Health Tech's own cyclotrons or by neutrons at different reactors in Europe and the US.
The medical isotopes are developed at the Hevesy Laboratory, which is named after George de Hevesy (1885 – 1966), who was awarded the Nobel Prize in chemistry in 1943 for his work on the use of isotopes as tracers in the study of chemical processes.
At the Hevesy Laboratory, radioactive isotopes are produced by means of a biomedical cyclotron donated by The John and Birthe Meyer Foundation in 2004.
The Hevesy Laboratory also includes production of Radiopharmaceuticals.